Syncom Formulations (India) Limited (SYNCOMF) - Total Assets

Latest as of September 2025: Rs4.56 Billion INR ≈ $49.32 Million USD

Based on the latest financial reports, Syncom Formulations (India) Limited (SYNCOMF) holds total assets worth Rs4.56 Billion INR (≈ $49.32 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See SYNCOMF total equity for net asset value and shareholders' equity analysis.

Syncom Formulations (India) Limited - Total Assets Trend (2006–2025)

This chart illustrates how Syncom Formulations (India) Limited's total assets have evolved over time, based on quarterly financial data.

Syncom Formulations (India) Limited - Asset Composition Analysis

Current Asset Composition (March 2025)

Syncom Formulations (India) Limited's total assets of Rs4.56 Billion consist of 65.3% current assets and 34.7% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	0.2%
Accounts Receivable	Rs1.29 Billion	31.1%
Inventory	Rs413.32 Million	10.0%
Property, Plant & Equipment	Rs0.00	0.0%
Intangible Assets	Rs472.00K	0.0%
Goodwill	Rs0.00	0.0%

Asset Composition Trend (2006–2025)

This chart illustrates how Syncom Formulations (India) Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see SYNCOMF company net worth.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Syncom Formulations (India) Limited's current assets represent 65.3% of total assets in 2025, an increase from 53.4% in 2006.
Cash Position: Cash and equivalents constituted 0.2% of total assets in 2025, down from 0.4% in 2006.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2006.
Asset Diversification: The largest asset category is accounts receivable at 31.1% of total assets.

Syncom Formulations (India) Limited Competitors by Total Assets

Key competitors of Syncom Formulations (India) Limited based on total assets are shown below.

Company	Country	Total Assets
Kangmei Pharmaceutical Co Ltd SHG:600518	China	CN¥13.68 Billion
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	China	CN¥4.44 Billion
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	China	CN¥10.96 Billion
Beijing Winsunny Pharmaceutical CO.LTD SHG:601089	China	CN¥4.69 Billion
KPC Pharmaceuticals Inc SHG:600422	China	CN¥12.01 Billion
Cronos Group Inc TO:CRON	Canada	CA$1.18 Billion
Cheng Du Sheng Nuo Biotec Co. Ltd. A SHG:688117	China	CN¥1.91 Billion
Jiangsu Jibeier Pharmaceutical Co Ltd SHG:688566	China	CN¥2.64 Billion

Syncom Formulations (India) Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	4.68	5.01	2.07
Quick Ratio	4.24	4.09	1.79
Cash Ratio	0.00	0.00	0.00
Working Capital	Rs2.39 Billion	Rs1.97 Billion	Rs601.61 Million

Syncom Formulations (India) Limited - Advanced Valuation Insights

This section examines the relationship between Syncom Formulations (India) Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	3.26
Latest Market Cap to Assets Ratio	0.04
Asset Growth Rate (YoY)	2.1%
Total Assets	Rs4.13 Billion
Market Capitalization	$149.13 Million USD

Valuation Analysis

Below Book Valuation: The market values Syncom Formulations (India) Limited's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Syncom Formulations (India) Limited's assets grew by 2.1% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Syncom Formulations (India) Limited (2006–2025)

The table below shows the annual total assets of Syncom Formulations (India) Limited from 2006 to 2025.

Year	Total Assets	Change
2025-03-31	Rs4.13 Billion ≈ $44.69 Million	+2.13%
2024-03-31	Rs4.05 Billion ≈ $43.76 Million	+7.10%
2023-03-31	Rs3.78 Billion ≈ $40.86 Million	+22.58%
2022-03-31	Rs3.08 Billion ≈ $33.33 Million	+5.69%
2021-03-31	Rs2.92 Billion ≈ $31.54 Million	+61.56%
2020-03-31	Rs1.81 Billion ≈ $19.52 Million	+4.37%
2019-03-31	Rs1.73 Billion ≈ $18.71 Million	+1.17%
2018-03-31	Rs1.71 Billion ≈ $18.49 Million	-5.11%
2017-03-31	Rs1.80 Billion ≈ $19.48 Million	+2.72%
2016-03-31	Rs1.75 Billion ≈ $18.97 Million	+27.47%
2015-03-31	Rs1.38 Billion ≈ $14.88 Million	-1.74%
2014-03-31	Rs1.40 Billion ≈ $15.14 Million	+13.97%
2013-03-31	Rs1.23 Billion ≈ $13.29 Million	+8.99%
2012-03-31	Rs1.13 Billion ≈ $12.19 Million	-0.29%
2011-03-31	Rs1.13 Billion ≈ $12.23 Million	+22.47%
2010-03-31	Rs923.19 Million ≈ $9.98 Million	+45.83%
2009-03-31	Rs633.06 Million ≈ $6.85 Million	-6.88%
2008-03-31	Rs679.82 Million ≈ $7.35 Million	+26.04%
2007-03-31	Rs539.38 Million ≈ $5.83 Million	+14.02%
2006-03-31	Rs473.07 Million ≈ $5.12 Million	--

About Syncom Formulations (India) Limited

NSE:SYNCOMF India Drug Manufacturers - Specialty & Generic

Market Cap

$149.13 Million

Rs13.79 Billion INR

Market Cap Rank

#17678 Global

#921 in India

Share Price

Rs14.67

Change (1 day)

-1.94%

52-Week Range

Rs10.30 - Rs22.15

All Time High

Rs26.77